{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:11:03Z","timestamp":1759529463694,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005614","name":"BC Cancer Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.jim.2010.07.003","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T04:30:19Z","timestamp":1279254619000},"page":"149-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies"],"prefix":"10.1016","volume":"360","author":[{"given":"Julie S.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin A.","family":"Wick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad H.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2010.07.003_bb0005","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.4161\/cbt.5.12.3353","article-title":"Transfection of human monocyte-derived dendritic cells with native tumor DNA induces antigen-specific T-cell responses in vitro","volume":"5","author":"Artusio","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jim.2010.07.003_bb0010","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.4049\/jimmunol.172.11.6649","article-title":"Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules","volume":"172","author":"Bonehill","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.07.003_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jim.2004.01.026","article-title":"The use of clonal mRNA as an antigenic format for the detection of antigen-specific T lymphocytes in IFN-gamma ELISPOT assays","volume":"287","author":"Britten","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.07.003_bb0020","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.180.4.1263","article-title":"Activation of human dendritic cells through CD40 cross-linking","volume":"180","author":"Caux","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2010.07.003_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(01)00535-X","article-title":"A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays","volume":"260","author":"Currier","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.07.003_bb0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/hum.2009.080","article-title":"Lumenal part of the DC-LAMP protein is not required for induction of antigen-specific T cell responses by means of antigen-DC-LAMP messenger RNA-electroporated dendritic cells","volume":"21","author":"De Keersmaecker","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jim.2010.07.003_bb0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/CJI.0b013e3180ca7cd6","article-title":"Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection","volume":"30","author":"Erdmann","year":"2007","journal-title":"J. Immunother."},{"key":"10.1016\/j.jim.2010.07.003_bb0040","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","article-title":"Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells","volume":"108","author":"Holtkamp","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.07.003_bb0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00262-007-0380-6","article-title":"Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC\/SVI)","volume":"57","author":"Janetzki","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jim.2010.07.003_bb0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ni1090","article-title":"Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII","volume":"5","author":"Kloetzel","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2010.07.003_bb0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00262-008-0556-8","article-title":"Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients","volume":"58","author":"Knights","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jim.2010.07.003_bb0060","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00262-007-0302-7","article-title":"Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA","volume":"56","author":"Kreiter","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jim.2010.07.003_bb0065","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/gt.2008.22","article-title":"RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma","volume":"15","author":"Mason","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.jim.2010.07.003_bb0070","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.4049\/jimmunol.163.11.5851","article-title":"Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides","volume":"163","author":"Mo","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.07.003_bb0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jim.2006.05.009","article-title":"Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells","volume":"314","author":"Naota","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.07.003_bb0080","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.4049\/jimmunol.169.4.1669","article-title":"Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells","volume":"169","author":"Ponsaerts","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.07.003_bb0085","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.4049\/jimmunol.169.4.1669","article-title":"Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells","volume":"169","author":"Ponsaerts","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.07.003_bb0090","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.4049\/jimmunol.180.5.3210","article-title":"Characterizing the N-terminal processing motif of MHC class I ligands","volume":"180","author":"Schatz","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.07.003_bb0095","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00262-008-0515-4","article-title":"Molecular mechanisms of MHC class I abnormalities and APM components in human tumors","volume":"57","author":"Seliger","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jim.2010.07.003_bb0100","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1089\/hum.2009.145","article-title":"Dendritic cell-based cancer gene therapy","volume":"20","author":"Smits","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jim.2010.07.003_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2010.01.009","article-title":"Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes","volume":"354","author":"Van Camp","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.07.003_bb0110","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2249.2005.02733.x","article-title":"Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells","volume":"139","author":"Van den Bosch","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2010.07.003_bb0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/14653240902960411","article-title":"Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial","volume":"11","author":"Van Driessche","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jim.2010.07.003_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0952-7915(00)00175-8","article-title":"Cut and trim: generating MHC class I peptide ligands","volume":"13","author":"Yewdell","year":"2001","journal-title":"Curr. Opin. Immunol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175910001997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175910001997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:33:07Z","timestamp":1758299587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175910001997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0022175910001997"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2010.07.003","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2010.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2010 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}